Catalent is a leading global CDMO that specializes in drug development and manufacturing. Our commitment is to collaborate closely with you to successfully bring your product to the clinic and market. Drawing on our expertise in PBPK modeling, bioavailability enhancement, API-sparing development techniques, and tailored dose forms, Catalent accelerates the progression of drug candidates to clinic. Utilizing data-driven strategies and advanced technologies globally, we help solve complex challenges to accelerate drug development processes.

Our integrated solutions, such as OptiForm® Solution Suite and Catalent Xpress Pharmaceutics®, facilitate the swift transition of molecules from candidate to clinic and beyond. Additionally, our proficiency in lipid-based drug delivery systems, spray drying, modified release, and particle-size reduction allows us to create optimal dosage forms for your program's objectives.

From early-phase development through clinical supplies to commercial manufacturing, Catalent is dedicated to partnering with you at every step to bring better treatments to patients reliably.